Xenetic Biosciences
XBIO
14 hedge funds and large institutions have $832K invested in Xenetic Biosciences in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
17% more funds holding
Funds holding: 12 → 14 (+2)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.17% less ownership
Funds ownership: 0.64% → 0.47% (-0.17%)
32% less capital invested
Capital invested by funds: $1.22M → $832K (-$385K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.8K |
| 2 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$20.2K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$10.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.55K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$182 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$222K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$82.3K |
| 3 |
VF
Virtu Financial
New York
|
-$81K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$59K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $288K | -$222K | -10,993 | -44% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $185K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $104K | -$82.3K | -4,079 | -44% |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $103K | +$38.8K | +1,925 | +62% |
|
|
JEST
5
JTC Employer Solutions Trustee
St Helier,
Jersey
| $55K | +$54.4K | +2,699 | New |
|
|
SPIA
6
Steward Partners Investment Advisory
New York
| $51K | – | – | – |
|
|
JMPWA
7
JP Morgan Private Wealth Advisors
San Francisco,
California
| $20K | +$20.2K | +1,000 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| $11K | +$8.55K | +424 | +437% |
|
|
9
Osaic Holdings
Scottsdale,
Arizona
| $10K | +$10.1K | +500 | New |
|
10
Morgan Stanley
New York
| $5K | – | – | – |
|
|
RE
11
RBC Europe
London,
United Kingdom
| $216 | – | – | – |
|
|
VF
12
Virtu Financial
New York
| – | -$81K | -3,720 | Closed |
|
|
13
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$59K | -2,699 | Closed |
|
|
14
Bank of America
Charlotte,
North Carolina
| – | +$182 | +9 | New |
|
XBIO Hedge Fund Activity: Q2 2021 in Review
14 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q2 2021, worth a combined $832K — down 32% from $1.22M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new XBIO positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $38.8K. The largest seller was Renaissance Technologies, cutting an estimated $222K.
- 14 institutional investors held Xenetic Biosciences (XBIO) as of Q2 2021, up from 12 in Q1 2021.
- Funds reported $832K of Xenetic Biosciences stock for Q2 2021, down 32% quarter-over-quarter.
- 4 funds opened new Xenetic Biosciences positions in Q2 2021 and 2 closed out, a net change of +2 holders.
- The largest Xenetic Biosciences buyer in Q2 2021 was Geode Capital Management, an estimated $38.8K added.
- The largest Xenetic Biosciences seller in Q2 2021 was Renaissance Technologies, an estimated $222K sold.
Based on aggregated 13F filings for Q2 2021.